General Information of Binding Target of SBP (BTS) (ID: ST00076)
BTS Name
CD40 ligand
Synonyms
CD40-L; T-cell antigen Gp39; TNF-related activation protein; TRAP; Tumor necrosis factor ligand superfamily member 5; CD antigen CD154
BTS Type
Protein
Family
Tumor necrosis factor family
Gene Name
CD40LG
Organism
Homo sapiens (Human)
Function
Cytokine that acts as a ligand to CD40/TNFRSF5 Costimulates T-cell proliferation and cytokine production Its cross-linking on T-cells generates a costimulatory signal which enhances the production of IL4 and IL10 in conjunction with the TCR/CD3 ligation and CD28 costimulation Induces the activation of NF-kappa-B Induces the activation of kinases MAPK8 and PAK2 in T-cells Induces tyrosine phosphorylation of isoform 3 of CD28 Mediates B-cell proliferation in the absence of co-stimulus as well as IgE production in the presence of IL4 (By similarity). Involved in immunoglobulin class switching (By similarity).; [CD40 ligand, soluble form]: Acts as a ligand for integrins, specifically ITGA5:ITGB1 and ITGAV:ITGB3; both integrins and the CD40 receptor are required for activation of CD40-CD40LG signaling, which have cell-type dependent effects, such as B-cell activation, NF-kappa-B signaling and anti-apoptotic signaling.
UniProt ID
P29965
UniProt Entry
CD40L_HUMAN
PFam
PF00229
Gene ID
959
Sequence
MIETYNQTSPRSAATGLPISMKIFMYLLTVFLITQMIGSALFAVYLHRRLDKIEDERNLH
EDFVFMKTIQRCNTGERSLSLLNCEEIKSQFEGFVKDIMLNKEETKKENSFEMQKGDQNP
QIAAHVISEASSKTTSVLQWAEKGYYTMSNNLVTLENGKQLTVKRQGLYYIYAQVTFCSN
REASSQAPFIASLCLKSPGRFERILLRAANTHSSAKPCGQQSIHLGGVFELQPGASVFVN
VTDPSQVSHGTGFTSFGLLKL
Sequence Length
261
Synthetic Binding Protein (SBP) Targeting This BTS
SBP Name Highest Status Mechanism Affinity Application Details Ref
Avimer anti-CD40L C65 Research Inhibitor Kd: <0.1 nM Research tool
SBP Info
[1]
Fab Dapirolizumab Phase III Inhibitor N.A. Systemic lupus erythematosus [ICD-11: 4A40.0]; Multiple sclerosis [ICD-11: 8A40.Z]; Amyotrophic lateral sclerosis [ICD-11: 8B60.0]; Rheumatoid Arthritis [ICD-11: FA20.Z]
SBP Info
[2]
References
1 Mult ivalent avimer proteins evolved by exon shuffling of a family of human receptor. Nat Biotechnol. 2005 Dec;23(12):1556-61.
2 Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles. Ann Rheum Dis. 2017 Nov;76(11):1837-1844.